Home > Compound List > Product Information
Paramethadione_Molecular_structure_CAS_115-67-3)
Click picture or here to close

Paramethadione

Catalog No. DB00617 Name DrugBank
CAS Number 115-67-3 Website http://www.ualberta.ca/
M. F. C7H11NO3 Telephone (780) 492-3111
M. W. 157.16714 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 499

SYNONYMS

IUPAC name
5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione
IUPAC Traditional name
@paramethadione
Brand Name
Paramethadione [BAN:INN]
Paradione
Paramethadionum [INN-Latin]
Isoethadione
Paradione (TN)
Parametadiona [INN-Spanish]
Parametadione
Parametadione [DCIT]

DATABASE IDS

PubChem SID 46509173
PubChem CID 8280
CAS Number 115-67-3

PROPERTIES

Hydrophobicity(logP) 0.3
Solubility 8.4 mg/mL

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.
Indication Used for the control of absence (petit mal) seizures that are refractory to treatment with other medications.
Pharmacology Paramethadione is an oxazolidinedione anticonvulsant similar to trimethadione that acts on the central nervous system (CNS) to reduce the number of absence seizures (often seen in epileptics). Absence seizures involve an interruption to consciousness where the person experiencing the seizure seems to become vacant and unresponsive for a short period of time (usually up to 30 seconds). Paramethadione acts on thalamic neurons in the thalamic reticular nucleus (which studies have shown to be associated with absence seizures, von Krosigk et al., 1993).
Toxicity Symptoms of overdose include clumsiness or unsteadiness, coma, severe dizziness, severe drowsiness, severe nausea, and problems with vision.
Affected Organisms
Humans and other mammals
Biotransformation Primarily hepatic (mainly via cytochrome P450 isozyme 2C9), paramethadione is completely demethylated to 5-ethyl-5-methyl-2,4-oxazolidinedione, the active metabolite.
Absorption Rapid via the digestive tract.
Half Life 12 to 24 hours (however the half-life for the active metabolite is not known)
Protein Binding Not significant
References
Hoffman DJ, Chun AH: Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose. J Pharm Sci. 1975 Oct;64(10):1702-3. [Pubmed]
Feldman GL, Weaver DD, Lovrien EW: The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Am J Dis Child. 1977 Dec;131(12):1389-92. [Pubmed]
External Links
Wikipedia
Drugs.com

REFERENCES

  • Hoffman DJ, Chun AH: Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose. J Pharm Sci. 1975 Oct;64(10):1702-3. Pubmed
  • Feldman GL, Weaver DD, Lovrien EW: The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Am J Dis Child. 1977 Dec;131(12):1389-92. Pubmed